Since his appointment in Addenbrooke’s hospital 9 + years ago as a formal UK-trained Consultant Oncoplastic Surgeon, Mr Agrawal has transformed Cambridge Breast Unit into a modern oncoplastic breast unit and a leading breast surgical unit attracting international surgical fellows.
He introduced the latest advanced oncoplastic breast-preserving operations (therapeutic mammaplasty, mastopexy, partial breast reconstruction with chest-wall perforator flap) and full breast reconstructive techniques (muscle-less mesh-based implant and muscle-less tissue only) locally.
Mr Agrawal is the founder-director of an international breast reconstructive dissection skills course that attracts national & international Consultants. He trained in breast surgical oncology and advanced oncoplastic and reconstructive breast surgery in Nottingham-Derby complemented by fellowships in Paris and Brussels.
He lectures nationally and internationally and has nearly 110+ papers and
presentations in both the science of breast oncology as well as on breast
He is Audit Lead in the Cambridge Breast Unit ensuring quality and leads by regularly seeking patient feedback (PROMS) on all oncoplastic & reconstructive procedures.
Treatments and tests offered by Mr Amit Agrawal at Nuffield Health
- Reconstructive surgery
- Breast uplift (mastopexy)
- Fat transfer
- Mastectomy (breast removal)
- Breast reconstruction
- Sentinel node biopsy
- Local anaesthetic
- Breast reduction
- Excisional biopsy
- Breast oncology
- Breast augmentation (enlargement)
He is receiving grants as a lead applicant and co-investigator in breast surgery studies. He is the research lead and faculty examiner in the MSc/MS Oncoplastic Breast Surgery degrees (UeA).
As Clinical lecturer in the university of Nottingham, he performed clinical and laboratory research in endocrine therapies deciphering mechanisms of resistance to endocrine therapy in breast cancer (collaborations with the Universities of Sheffield and Cardiff). His original work on such resistance mechanisms in the pure anti-oestrogen drug FaslodexTM (AstraZeneca) led to a DM research degree award.
- Association of Breast Surgery, UK
- European Society of Surgical Oncology
- British Breast Group
- Bristish Medical Association
Other posts held
- Cambridge University Hospitals, Consultant Oncoplastic & Reconstructive Breast Surgeon
Insurers Mr Amit Agrawal works with
Mr Amit Agrawal works with the following private medical insurance providers:
- Aviva Health
- AXA - Global Healthcare
- AXA Health
- Bupa On Demand
- CS Healthcare
- Exeter Family Friendly
- Vitality Health (Pru Health)
- Westfield Health WPA
- Universal Provident
Mr Amit Agrawal does not hold a share or financial interest in this hospital, another Nuffield Health hospital or the company.
Mr Amit Agrawal does not have a share or financial interest in equipment used at this hospital or another Nuffield Health hospital.
Mr Amit Agrawal does not hold any paid advisory role(s) at this hospital or on behalf of Nuffield Health.